Menu

Launch-at-Risk Analysis

Intensity worked with a generic pharmaceutical company to evaluate potential risks
and rewards in an “launch-at-risk” generic drug. Intensity’s complex, scenario-based
modeling provided key insights and drove economically informed decision making.

Read the full case study: Intensity_Case_Study_Launch_Risk_Analysis